Hide menu

Gender difference for cardiac care

Women treated for severe heart attacks are less often than men to receive coronary angioplasty treatment according to a Linköping University study presented in Paris at the on-going European Society of Cardiology Congress (ESC).

Behind the study are, among others, Eva Swahn, Professor of Cardiology and specialist Sofia Lawesson.

They examined data from more than 30,000 patients and compared treatment dispensed over a decade. In the 90s, clot-dissolving agents were the dominant treatment, which more often caused side effects, such as bleeding, in women. Therefore, fewer women than men received the treatment.

During early 2000s a different approach took hold, namely dilation of the blocked blood vessel using surgical balloons, which causes less side effects. Nevertheless, the Linköping study indicates that a gender gap still exists: compared with men, 20 % fewer women received this treatment.

Even post-operative treatments displayed noticeable differences for medication of men and women.

Text: Åke Hjelm


Page manager: johan.jager@liu.se
Last updated: 2012-12-10